Eden Share Price (EDEN)

NB for clarity, I wasn't told that it was certain that the nit treatment would be licensed this year, merely that all was going well with that up to then, and given the impression that all being well, not too much longer to wait. Cedroz, licensing in full only given in Malta, in Italy the emergency temporary licence pending hopefully formal permanent licensing to follow, and I think there were 5 or 6 other southern or middle European countries where Eden had applied for Cedroz licensing which is supposed to follow within 3 months of grant in the first EU country (Malta), but with Mevalone I recall France took more like 9 months not 3 months after the first EU country had licensed Mevalone, so you can't rely on within-3-months (I think it's already now more than 3 months, or almost, since the grant of the license for Cedroz in Malta). I recall a commentator claiming that the market for nematicides like Cedroz = an even bigger total value market than the market for treatments (like Mevalone) for botrytis in grapes/melons/other fruit, by some margin, but haven't verified that for myself.

If you want something promptish on Eden, we should discover whether or not end July, all of august and various parts of September depending on grape variety and location in the licensed Mevalone area, i.e. lateish in the growing season of various grapes on which you don’t want Botrytis (that’s most grapes, you only want the “noble rot” on a few grown as desert wines), are wet or not. Last year was the first year of Mevalone licensing in France and Portugal but annoyingly it was dry. An English vineyard I visited (NB Mevalone not licensed in UK as not much wine grown) last September and asked about this on the tour, told me it was the first year they had ever NOT had to use botrytis treatment. As an Eden investor my heart rather sank at this news. It is the last few weeks, especially last fortnight before harvest, when Botrytis is most likely to develop, and other treatments unlike Mevalone can’t be used a few days prior to harvest; Mevalone can be used right up to actual harvest. A rainy or average summer and early autumn, at east not drier than usual, will generate good, I hope, Mevalone sales.

As to Cedroz, we have an emergency licence of this nematicide to kill soil worms in Italy pending full approval, as it is so valuable that Italian growers didn’t want to wait. And as to the nit treatment, Sean told me personally that he was optimistic about USA licensing completing (unable to give a specific timeframe but later this year, that was early Spring), and following two delays for the UK nit treatment launch by marketing partner Terpentech (due Sept 2018, delayed to Jan 2019, delayed again to Sept 2019, delays TT’s fault – Eden was ready and able to produce the product in marketable form), I hope for imminent confirmation of September 2019 launch. By January we were told the first budget supermarkets had signed up (interpreted by some commentators to be Aldi and/or Lidl but could have been Tesco or Morrisons – they didn’t say), so it was only a case of assigning a brand and packaging, and getting a firm to bottle the stuff up. Most nit treatments sell for about £7 a bottle.

So that’s three sources of potentially prompt-ish news, whether good or bad, for Eden. I thought I’d remind us all of that, because Eden’s so bad at comms, and doesn’t !!!

Or are you really saying that you think that the competition's products are in some way superior.
-------------
We just don't know.

If the nit treatment is to launch in September 2019 as the marketing partner previously promised, as announced by Sean the CEO at the pro active investors Eden event early in the spring, then there ought to be an RNS about the marketing channels and arrangements at some stage not too far away

ash666
Forgive me please, there is no doubt whatsoever that competition increases the market size and brings about innovation and technological advance.
Any manager who is unable to embrace this concept is in the wrong job.
It is bad management that brings down companies.
There are numerous smaller companies who are head to head with multi-nationals, yet they thrive.
Or are you really saying that you think that the competition's products are in some way superior, if so please produce proof.
With thanks.